课题基金 / 基金详情

Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20

Regulation of B-arrestin2's pro-atherogenic activity by the deubiquitinase USP20
去泛素酶 USP20 对 B-arrestin2 促动脉粥样硬化活性的调节
批准号:
8639259
负责人:
NEIL J. FREEDMAN
金额:
$47.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-03 至 2018-01-31

项目摘要

项目成果

NEIL J. FREEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Atherosclerosis remains a leading cause of death in the United States. Accumulating evidence suggests that aortic wall smooth muscle cell gene expression contributes substantially to atherogenesis. ß-arrestin2 (ßarr2) an endocytic and signaling adaptor for G protein-coupled receptors (GPCRs), growth factor receptors and ion- channels is also known to promote neointimal hyperplasia and atherosclerosis in mice. Reversible ßarr2 ubiquitination, as regulated by deubiquitinases (DUBs) is a critical post-translational modification that is required for ßarr2's adaptor functions in mediating cell-signaling. Our Preliminary Studies suggests that the DUB USP20 might affect ßarr2 ubiquitination as well as NFκB signaling induced by the atherogenic Toll-like receptor 4 (TLR4). To delineate the role(s) of ßarr2 ubiquitination/deubiquitination dynamics in vivo and to evaluate whether the ubiquitination status of ßarr2 could engender pro-inflammatory signaling in SMCs, we have generated transgenic mice expressing USP20 or its catalytically inactive isoform (DN-USP20) under control of the SMC-specific SM22α promoter. In this model, we expect that by de-ubiquitinating ßarr2, USP20 would reduce ßarr2 activity and thereby reduce the SMC pro-atherogenic proliferation and migration that engenders neointimal hyperplasia, whereas the DN-USP20 would have reciprocal effects. By utilizing these and additional novel reagents and in vivo methods involving diet and gene-dependent atherosclerosis and in vitro techniques employing primary vascular smooth muscle cells we will test the hypotheses that USP20 in SMCs mitigates atherosclerosis through mechanisms involving deubiquitination of ßarr2, and/or deubiquitination of TRAF6 or TRAF2 in a manner dependent upon ßarr2 scaffolding by accomplishing following specific aims: (1) To determine the atheroprotective role of SMC USP20, and whether USP20's mechanism of action requires de-ubiquitination of ßarr2 (2) To determine whether USP20 activity regulates ßarr2-dependent SMC proliferation, migration and signaling triggered by inflammatory stimuli and (3) To elucidate the mechanistic basis of USP20's effects on ßarr2-dependent signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
  • 批准号:
    10670399
  • 项目类别:
  • 资助金额:
    $58.7万
  • 财政年份:
    2022
  • 负责人:
    NEIL J. FREEDMAN
  • 依托单位:
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
  • 批准号:
    10502380
  • 项目类别:
  • 资助金额:
    $58.7万
  • 财政年份:
    2022
  • 负责人:
    NEIL J. FREEDMAN
  • 依托单位:
Anti-Atherogenic Mechanisms of Drebrin
  • 批准号:
    10318175
  • 项目类别:
  • 资助金额:
    $52.33万
  • 财政年份:
    2019
  • 负责人:
    NEIL J. FREEDMAN
  • 依托单位:
Anti-Atherogenic Mechanisms of Drebrin
  • 批准号:
    10532356
  • 项目类别:
  • 资助金额:
    $52.33万
  • 财政年份:
    2019
  • 负责人:
    NEIL J. FREEDMAN
  • 依托单位:
海外基金